News

GlaxoSmithKline Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceuticals, Service Income and Other Operating Revenue for the year ending 31-Mar-2024.For the quarter ended 31-12-2024, ...
The vote, 14 to 0 with one abstention, could lift sales for the three RSV vaccine makers: GSK Plc, Pfizer Inc. and Moderna ...
A municipal worker cleans the area outside Hellenic Train headquarters, Greece's main railway company, following a bomb explosion Friday night causing causing limited damage but no injuries ...
It was followed by rival GSK, which tumbled 5.7 per cent, or 76.5p, to 1264p. The slump in drugmakers’ stocks came after the US president said overnight that the US would soon introduce a ...
GSK recently announced the FDA approval of Blujepa, a first-in-class antibiotic for urinary tract infections, and the EMA's acceptance of an application for Nucala's expanded use. Despite these ...
GSK is funding public health organizations working to address US adult immunization gaps and increase community vaccine education, outreach and access These grants are part of GSK’s COiMMUNITY ...
Goodwill San Francisco Bay, a local unit of the nationwide clothing-and-jobs charity network, plans to shutter its San Francisco headquarters and close its by-the-pound store in Oakland.
Pfizer and GlaxoSmithKline have agreed to end a lawsuit over alleged patent infringement involving their competing respiratory syncytial virus (RSV) vaccines, according to a filing made in Delaware ...
South Carolina is selling the longtime headquarters of its Department of Mental Health. Provided Google Maps State officials have put the building that houses the South Carolina Department of ...
On April 3, 2025, GlaxoSmithKline (GSK) and Pfizer filed a stipulation to dismiss with prejudice GSK’s litigation in the United States District Court for the District of Delaware. GSK filed suit ...
COLUMBUS, Ohio — Ohio Attorney General Dave Yost is pushing to take a leading role in a federal securities lawsuit that accuses pharmaceutical giant GSK, formerly GlaxoSmithKline, of concealing the ...
South Ko­re­an biotech ABL Bio has lined up an­oth­er plat­form li­cense agree­ment with a Eu­ro­pean phar­ma gi­ant in the area of neu­rode­gen­er­a­tive dis­eases.